Gresser I
Laboratory of Viral Oncology, Groupe de Laboratoires de L'Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Acta Oncol. 1989;28(3):347-53. doi: 10.3109/02841868909111205.
Both natural and recombinant interferons have shown definite antitumor activity in some patients with some malignancies. The history of the development of interferon as an antitumor agent is reviewed, with special attention to its use in mice bearing 'spontaneously' appearing tumors and in mice injected with tumorigenic viruses or transplantable tumor cells. Interferon can inhibit the growth of primary tumors as well as the development of metastases. These experimental results have provided some indications as to the probable optimal regimens of interferon administration in man. Although the mechanisms of interferon's antitumor activity are unknown, it seems likely that interferon can act directly on the tumor cells as well as on the tumor bearing host.
天然干扰素和重组干扰素在一些患有某些恶性肿瘤的患者中均已显示出明确的抗肿瘤活性。本文综述了干扰素作为抗肿瘤药物的发展历程,特别关注了其在患有“自发”出现肿瘤的小鼠以及注射致瘤病毒或可移植肿瘤细胞的小鼠中的应用。干扰素可以抑制原发性肿瘤的生长以及转移的发生。这些实验结果为人类使用干扰素的可能最佳方案提供了一些线索。虽然干扰素抗肿瘤活性的机制尚不清楚,但干扰素似乎可能直接作用于肿瘤细胞以及荷瘤宿主。